Immix Biopharma, Inc.'s total assets for Q were $25.14M, a decrease of -12.81% from the previous quarter. IMMX total liabilities were $7.59M for the fiscal quarter, a 53.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.